---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-003725"
form_type: "8-K"
ticker: "UPXI"
cik: "0001775194"
company_name: "UPEXI, INC."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:08:46.404696+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Upexi sells VitaMedica subsidiary for $6M; CEO-controlled entity part of buyer group

## Summary
- Sold 100% of VitaMedica to group including MFA Holdings (controlled by CEO Allan Marshall) for $6M.
- Received $4M cash at closing; $1M promissory note due in 12 months; $1M payable on 15-month anniversary.
- Transaction closed June 13, 2024 under SPA dated June 1, 2024.
- Upexi retains no ongoing interest in VitaMedica.

## SEC filing metadata
- accession: 0001477932-24-003725
- form_type: 8-K
- ticker: UPXI
- cik: 0001775194
- company_name: UPEXI, INC.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1775194/000147793224003725/0001477932-24-003725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1775194/000147793224003725/upxi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-003725
- JSON: https://secwatch.observer/filing/0001477932-24-003725.json
- Plain text: https://secwatch.observer/filing/0001477932-24-003725.txt

## Key facts
- M&A Transactions
  UPEXI, INC. completed a disposition involving Nutra Products LLC, MFA Holdings Corp., and 1000915944 Ontario Inc. for $6,000,000 (closed 2024-06-13).
  - Action: disposition
  - Counterparty: Nutra Products LLC, MFA Holdings Corp., and 1000915944 Ontario Inc.
  - Consideration: $6,000,000
  - Closing: 2024-06-13
  source text: Stock Purchase Agreement dated June 1, 2024. MFA Holdings, Corp. is controlled by Allan Marshall, the Company’s CEO and Chairman. The purchase price in the sale transaction was $6,000,000, of which (i) $4,000,000 was paid in cash at closing, (ii) $1,000,000 is in the form of promissory notes issued by the Buyers to the Company, which promissory notes are payable in
  evidence_url: https://www.sec.gov/Archives/edgar/data/1775194/000147793224003725/0001477932-24-003725-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.